ADMA Biologics, Inc. (ADMA)
Largest Insider Buys in Sector
ADMA Stock Price History Chart
ADMA Stock Performance
About ADMA Biologics, Inc.
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed …
Insider Activity of ADMA Biologics, Inc.
Over the last 12 months, insiders at ADMA Biologics, Inc. have bought $0 and sold $25.17M worth of ADMA Biologics, Inc. stock.
On average, over the past 5 years, insiders at ADMA Biologics, Inc. have bought $6.33M and sold $13.36M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 130,000 shares for transaction amount of $482,144 was made by Grossman Jerrold B (director) on 2023‑08‑30.
List of Insider Buy and Sell Transactions, ADMA Biologics, Inc.
| 2024-09-09 | Sale | director | 9,000 0.0039% | $18.47 | $166,189 | +5.25% | ||
| 2024-08-30 | Sale | COO and SVP, Compliance | 24,150 0.0101% | $16.90 | $408,050 | +9.99% | ||
| 2024-08-29 | Sale | director | 136,861 0.0589% | $17.27 | $2.36M | +9.61% | ||
| 2024-08-27 | Sale | President and CEO | 389,356 0.1665% | $17.29 | $6.73M | +6.89% | ||
| 2024-08-26 | Sale | President and CEO | 236,889 0.103% | $17.69 | $4.19M | +5.27% | ||
| 2024-08-23 | Sale | director | 60,000 0.0255% | $18.26 | $1.1M | -0.60% | ||
| 2024-06-14 | Sale | President,CEO, and Interim CFO | 100,000 0.044% | $10.72 | $1.07M | +61.67% | ||
| 2024-03-19 | Sale | director | 411,829 0.1772% | $6.08 | $2.5M | +82.55% | ||
| 2024-03-18 | Sale | director | 49,887 0.0221% | $6.01 | $299,821 | +87.79% | ||
| 2024-03-15 | Sale | director | 183,008 0.0805% | $6.01 | $1.1M | +83.81% | ||
| 2024-03-14 | Sale | director | 448,276 0.1906% | $6.05 | $2.71M | +82.89% | ||
| 2024-03-13 | Sale | director | 407,000 0.1776% | $6.21 | $2.53M | +75.88% | ||
| 2023-08-30 | director | 130,000 0.0588% | $3.71 | $482,144 | +44.74% | |||
| 2023-08-24 | director | 25,000 0.0108% | $3.90 | $97,500 | +36.05% | |||
| 2023-08-22 | Sale | director | 1.43M 0.637% | $3.87 | $5.54M | +35.92% | ||
| 2023-08-18 | Sale | President and CEO | 250,000 0.1139% | $4.15 | $1.04M | +27.07% | ||
| 2023-08-16 | Sale | President and CEO | 3 <0.0001% | $4.38 | $13 | +16.78% | ||
| 2023-08-16 | Sale | EVP, CFO | 178,184 0.0804% | $4.45 | $793,400 | +16.78% | ||
| 2023-08-15 | Sale | President and CEO | 510,469 0.2298% | $4.54 | $2.32M | +14.10% | ||
| 2023-08-15 | Sale | EVP, CFO | 211,578 0.0964% | $4.60 | $972,730 | +14.10% |
Insider Historical Profitability
| Grossman Adam S | President and CEO | 2059726 0.8713% | $19.04 | 37 | 6 | <0.0001% |
| Grossman Jerrold B | director | 467305 0.1977% | $19.04 | 17 | 1 | <0.0001% |
| KWON YOUNG | director | 241441 0.1021% | $19.04 | 2 | 1 | +57.32% |
| Guiheen Lawrence P. | director | 153941 0.0651% | $19.04 | 5 | 1 | <0.0001% |
| PERCEPTIVE ADVISORS LLC | 10 percent owner | 13262375 5.6104% | $19.04 | 3 | 9 | <0.0001% |
Institutional Investor Ownership
| BlackRock | $120.12M | 7.85 | 18.2M | +1.57% | +$1.86M | <0.01 | |
| The Vanguard Group | $83.75M | 5.47 | 12.69M | -1.57% | -$1.34M | <0.01 | |
| State Street | $69.65M | 4.55 | 10.55M | +11.28% | +$7.06M | <0.01 | |
| Nuveen | $69.06M | 4.51 | 10.46M | -7.87% | -$5.9M | 0.02 | |
| Invesco | $51.51M | 3.37 | 7.8M | +27.69% | +$11.17M | 0.01 |